Skip to content

DBVT

DBV Technologies SA

NASDAQ · Healthcare · Biotechnology · FR

$12.35
−1.28%
Ask drillr

Next report

Analyst consensus

Next report date
Oct 28, 2026
EPS estimate
-$0.16
Revenue estimate
$664.0K

Latest reported

Last report date
Jul 16, 2026
EPS actual
-$0.14
EPS estimate
-$0.12
Revenue actual
$800.2K
Revenue estimate
$778.2K

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
5
EPS in line (12Q)
1
Avg surprise (4Q)
-71.4%
Revenue beats (12Q)
5
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Jul 16, 2026-$0.12-$0.14Miss -14.32%$800.2K
Apr 30, 2026-$0.14-$0.56Miss -300.00%$1.1M
Mar 26, 2026-$1.30-$1.15Beat 11.54%$577.6K
Oct 28, 2025-$1.45-$1.20Beat 17.24%$3.2M
Jul 29, 2025-$0.21-$1.55Miss -638.10%$1.7M
Apr 30, 2025-$0.24-$0.26Miss -8.33%$906.4K
Mar 27, 2025-$2.00-$1.20Beat 40.00%$553.1K
Mar 7, 2024-$0.32-$0.12Beat 62.50%$2.4M
May 4, 2023-$0.50-$0.22Beat 56.00%$2.4M
Mar 2, 2023-$2.30-$2.30In line-$1.4M
Nov 3, 2022-$0.32-$0.18Beat 43.75%$2.0M
Aug 1, 2022-$1.70-$1.80Miss -5.88%$1.6M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026